Cancer stage | No. of patients | Early failure | P-value |
---|
Early stage* | 62 (73.8) | 8 (12.9) | < 0.001 |
Advanced stage† | 22 (26.2) | 13 (59.1) | |
Total | 84 | 21 (25.0) | |
- Data are expressed as n (%)
- For patients with synchronous primary cancers, the more advanced stage was selected as the reference
- *Early stage defined as patients with TNM stage 1–2 or multiple myeloma patients with International Staging System (ISS) stage 1–2
- †Advanced stage defined as patients with TNM stage 3–4 or multiple myeloma patients with ISS stage 3